IN2013MU01157A - - Google Patents

Info

Publication number
IN2013MU01157A
IN2013MU01157A IN1157MU2013A IN2013MU01157A IN 2013MU01157 A IN2013MU01157 A IN 2013MU01157A IN 1157MU2013 A IN1157MU2013 A IN 1157MU2013A IN 2013MU01157 A IN2013MU01157 A IN 2013MU01157A
Authority
IN
India
Prior art keywords
topiramate
salts
composition
pharmaceutical compositions
relates
Prior art date
Application number
Other languages
English (en)
Inventor
Girish Kumar Jain
Venkataramana Naidu
Atul Patil
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN1157MU2013 priority Critical patent/IN2013MU01157A/en
Priority to PCT/IB2014/060054 priority patent/WO2014167439A1/en
Publication of IN2013MU01157A publication Critical patent/IN2013MU01157A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1157MU2013 2013-03-26 2014-03-22 IN2013MU01157A (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN1157MU2013 IN2013MU01157A (es) 2013-03-26 2014-03-22
PCT/IB2014/060054 WO2014167439A1 (en) 2013-03-26 2014-03-22 Modified release pharmaceutical compositions of topiramate or salts thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1157MU2013 IN2013MU01157A (es) 2013-03-26 2014-03-22

Publications (1)

Publication Number Publication Date
IN2013MU01157A true IN2013MU01157A (es) 2015-04-24

Family

ID=54395435

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1157MU2013 IN2013MU01157A (es) 2013-03-26 2014-03-22

Country Status (1)

Country Link
IN (1) IN2013MU01157A (es)

Similar Documents

Publication Publication Date Title
PH12020500352A1 (en) Therapeutic uses of empagliflozin
BR112014032699A2 (pt) métodos de tratamento de síndrome metabólica pediátrica
UA109991C2 (xx) Карбаматні сполуки, їх отримання і застосування
SG10201810888XA (en) Compositions and methods comprising bupropion or related compounds and dextromethorphan
MY180311A (en) Substituted benzene compounds
MX2013011922A (es) Compuestos de benceno substituido.
NZ629996A (en) 2’- substituted carba-nucleoside analogs for antiviral treatment
MX2015013948A (es) Composicion farmaceutica, metodos para tratamiento y sus usos.
IN2015DN03219A (es)
MX2016005446A (es) Intervenciones a base de angiopoyetina para tratar la malaria cerebral.
MX2016000294A (es) Composicion farmaceutica para liberacion sostenida de lanreotida.
AU2012280776B2 (en) Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases
BR112012022209A2 (pt) composições farmacêuticas compreendendo monoterpenos
BR102012028120B8 (pt) Uso de um ou mais derivados de ingenol, composição farmacêutica e medicamento
MX366309B (es) Composicion farmaceutica para el tratamiento de inflamacion y dolor.
BR112015007095A8 (pt) derivados de di-hidro-6-azafenaleno para o tratamento de doenças do snc, oncológicas e distúrbios relacionados, composição farmacêutica compreendendoos e uso dos referidos derivados
MX365021B (es) Composicion para tratar o prevenir enfermedades ocasionadas por permeabilidad vascular, que contiene como ingrediente activo imatinib o una sal farmaceuticamente aceptable del mismo.
IN2013MU01157A (es)
IN2013MU01156A (es)
IN2013MU01245A (es)
IN2013MU01248A (es)
IN2013MU01249A (es)
IN2013MU01250A (es)
IN2013MU01247A (es)
IN2013MU01246A (es)